The claim: Ivermectin is an effective treatment for COVID-19. Several states have logged 1 million coronavirus cases as the highly contagious delta variant continues to wreak havoc across the ...

Measles, mumps, and rubella (MMR) vaccination rates in children declined in some counties across the U.S. during the COVID-19 pandemic, researchers found. Across 2,066 counties in 33 states with both ...

Changes in COVID-19 test positivity within a week Data collected by the CDC shows that six Southern states making up Region 6 had the biggest decrease (-4.4%) in positive COVID-19 cases from Aug ...

Top health officials actively took steps to "delay warning the public" for months in 2021 about the potential risks of heart-related complications from receiving mRNA COVID-19 vaccines, a scathing ...

Summer wave of COVID-19 hitting U.S. 04:33 More than half of states are now seeing "high" or "very high" levels of SARS-CoV-2, the virus that causes COVID-19, in their wastewater testing ...

The Food and Drug Administration is shifting its annual COVID-19 vaccine approval policies to focus on Americans older than age 65 and other "high-risk" individuals, while increasing the standard ...

COVID-19 remained at 'very high' activity levels across the US: See latest data Newest CDC data shows nearly half of US states have 'very high' wastewater activity levels. Ahjané Forbes.

New data from the U.S. Centers for Disease Control and Prevention revealed which U.S. states had "very high" levels of SARS-CoV-2—the virus that causes COVID-19—present in wastewater between ...

MOVe-NOW (MK-4482-023, NCT06667700) is a Phase 3 multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of orally administered LAGEVRIO compared with ...

COVID-19 cases in Wisconsin and across nearly half of the United States are at "high" and "very high" levels of activity at the end of the summer, according to data from the Centers for Disease ...

Experts warn about risks of new COVID-19 vaccine guidelines 04:32. The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for ...